| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |